Inventor
David Askin
Inventor
Warren, NJ, US
Overview
Patents· 32 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
C07Dprimary
C07DHeterocyclic compounds55%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations21%
C07FAcyclic, carbocyclic or heterocyclic compounds containing elements other than carbon, hydrogen, halogen, oxygen, nitrogen, sulfur, selenium or tellurium7%
Y02PClimate change mitigation technologies in the production or processing of goods7%
C07CAcyclic or carbocyclic compounds4%
A61KPreparations for medical, dental or toiletry purposes2%
C07HSugars2%
C07KPeptides2%
PatentTitleYear
9,790,190'Process for making hydroxylated cyclopentylpyrimidine compounds'20179,676,730'Process for making hydroxylated cyclopentylpyrimidine compounds'20179,416,110'Process for making hydroxylated cyclopentylpyrimidine compounds'20167,598,264'HIV integrase inhibitors'20096,642,237'Gamma-hydroxy-2-(fluoroalkylaminocarbonyl)-1-piperazinepentanamides and uses thereof'20036,388,083'Process for the synthesis of (2S)-phenyl-3-piperidone'20026,239,280'Process for synthesizing biaryl inhibitors of farnesyl-protein transferase'20016,160,118'Process for the synthesis of substituted piperazinones via Mitsunobu reaction'20006,140,508'Process for making 1,5-disubstituted imidazoles'20006,071,916'HIV protease inhibitor'20005,929,243'Process for the preparation of (S)-3-carbethoxy-3-benzylpiperidine'19995,861,512'Process for making HIV protese inhibitors'19995,728,840'Process for making an epoxide'19985,723,615'Process for preparing 4-tert-butyloxycarbonyl-(S)-piperazine-2-tert-butylcarboxamide'19985,693,803'Process for making HIV protease inhibitors'19975,663,341'Process for making HIV protease inhibitors'19975,637,711'Process for making HIV protease inhibitors'19975,618,937'Process to make HIV protease inhibitor from (2S)-4-picolyl-2-piperazine-t-butylcarboxamide'19975,618,939'Process for making HIV protease inhibitors'19975,612,484'Process for making HIV protease inhibitors'19975,508,404'Reductive amination process'19965,496,948'Process for making HIV protease inhibitors'19965,491,238'Process for making HIV protease inhibitors'19965,463,067'Process for making HIV protease inhibitors'19955,446,158'Process for synthesis of FK-506 and tricarbonyl intermediates'19955,235,066'FK-506 type macrolide intermediate'19935,169,952'Stereoselective production of hydroxyamide compounds from chiral .alpha.-amino epoxides'19925,164,525'Synthetic process for FK-506 type macrolide intermediates'19925,087,703'Process for synthesis of FK-506 intermediates'19924,980,466'Hydroxide mediated FK-506 rearrangement product'19904,920,218'Novel hydroxide mediated FK-506 rearrangement process'19904,820,850'Process for .alpha.-C-alkylation of the 8-acyl group on mevinolin and analogs thereof'1989Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
1989–2009Patents assigned to MERCK & CO INC (29)· patent assignee history
1989–1995Based in Edison, NJ, US· patent location history
1992–2009Based in Warren, NJ, US· patent location history
2016–2017Patents assigned to ARRAY BIOPHARMA INC (3)· patent assignee history
2016–2017Patents assigned to GENENTECH INC (3)· patent assignee history
2016–2017Based in South San Francisco, CA, US· patent location history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| MERCK & CO INC | 29 | 1989–2009 |
| ARRAY BIOPHARMA INC | 3 | 2016–2017 |
| GENENTECH INC | 3 | 2016–2017 |
Locations
| Location | Patents | Span |
|---|---|---|
| Warren, New Jersey, US | 22 | 1992–2009 |
| Edison, New Jersey, US | 7 | 1989–1995 |
| South San Francisco, California, US | 3 | 2016–2017 |